Children's Hospital of Philadelphia: Researchers Find No Benefit to Higher Red Cell Transfusions in Preterm Infants
January 12, 2021
January 12, 2021
PHILADELPHIA, Pennsylvania, Jan. 12 (TNSJou) -- Children's Hospital of Philadelphia issued the following news:
A collaborative group of researchers, led by Children's Hospital of Philadelphia (CHOP), found that a higher hemoglobin threshold for red blood cell transfusions in anemic, extremely-low-birth-weight newborns does not improve survival or reduce neurodevelopmental impairment by age 2. The study, which is the largest on this topic to date, was recently published in . . .
A collaborative group of researchers, led by Children's Hospital of Philadelphia (CHOP), found that a higher hemoglobin threshold for red blood cell transfusions in anemic, extremely-low-birth-weight newborns does not improve survival or reduce neurodevelopmental impairment by age 2. The study, which is the largest on this topic to date, was recently published in . . .